Roya Behrouzi

2.6k total citations
11 papers, 184 citations indexed

About

Roya Behrouzi is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roya Behrouzi has authored 11 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roya Behrouzi's work include Lung Cancer Research Studies (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Roya Behrouzi is often cited by papers focused on Lung Cancer Research Studies (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Roya Behrouzi collaborates with scholars based in United Kingdom, Switzerland and Italy. Roya Behrouzi's co-authors include Martin Punter, Chloe E. Barr, Emma J. Crosbie, Katie Stocking, Philip W. Pemberton, Andrew Robinson, Rhona J. McVey, Hisham Hamdalla, Yvonne S. Davidson and Michael J. Strong and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Trends in Molecular Medicine.

In The Last Decade

Roya Behrouzi

10 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roya Behrouzi United Kingdom 7 71 46 43 39 31 11 184
Dagmara Klasa-Mazurkiewicz Poland 8 37 0.5× 88 1.9× 31 0.7× 62 1.6× 65 2.1× 34 250
Claire Edgerly United States 7 18 0.3× 66 1.4× 53 1.2× 34 0.9× 57 1.8× 17 185
Jérôme Meunier France 9 81 1.1× 21 0.5× 16 0.4× 53 1.4× 113 3.6× 26 217
A.M. Guedj France 9 19 0.3× 125 2.7× 19 0.4× 98 2.5× 15 0.5× 13 335
N Sato Japan 6 12 0.2× 104 2.3× 173 4.0× 309 7.9× 40 1.3× 17 421
Javier de la Torre Spain 11 45 0.6× 62 1.3× 135 3.1× 113 2.9× 46 1.5× 24 301
Anne‐Sophie Chong Canada 9 15 0.2× 51 1.1× 6 0.1× 37 0.9× 32 1.0× 16 251
Anand Murugasu Australia 8 15 0.2× 22 0.5× 13 0.3× 7 0.2× 32 1.0× 20 151
C J Lips Netherlands 8 164 2.3× 75 1.6× 38 0.9× 31 0.8× 159 5.1× 9 390
Qiaoying Lv China 12 6 0.1× 81 1.8× 85 2.0× 75 1.9× 35 1.1× 24 275

Countries citing papers authored by Roya Behrouzi

Since Specialization
Citations

This map shows the geographic impact of Roya Behrouzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roya Behrouzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roya Behrouzi more than expected).

Fields of papers citing papers by Roya Behrouzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roya Behrouzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roya Behrouzi. The network helps show where Roya Behrouzi may publish in the future.

Co-authorship network of co-authors of Roya Behrouzi

This figure shows the co-authorship network connecting the top 25 collaborators of Roya Behrouzi. A scholar is included among the top collaborators of Roya Behrouzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roya Behrouzi. Roya Behrouzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Behrouzi, Roya & Fiona Blackhall. (2025). State of the art in treatment of small cell lung cancer. Therapeutic Advances in Medical Oncology. 17. 22808254–22808254.
2.
Behrouzi, Roya, Alexandra Clipson, Kathryn Simpson, et al.. (2024). Cell-free and extrachromosomal DNA profiling of small cell lung cancer. Trends in Molecular Medicine. 31(1). 64–78. 7 indexed citations
3.
Behrouzi, Roya, Anne Armstrong, & Sacha J. Howell. (2023). CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis. Breast Cancer Research and Treatment. 202(1). 83–95. 3 indexed citations
4.
Behrouzi, Roya, Alessio Signori, Judith Cave, et al.. (2023). Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. Frontiers in Oncology. 13. 6 indexed citations
5.
Behrouzi, Roya, Alessio Signori, Judith Cave, et al.. (2023). The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. International Journal of Molecular Sciences. 24(2). 1746–1746. 3 indexed citations
6.
7.
Behrouzi, Roya, Chloe E. Barr, & Emma J. Crosbie. (2021). HE4 as a Biomarker for Endometrial Cancer. Cancers. 13(19). 4764–4764. 53 indexed citations
8.
9.
Behrouzi, Roya & Martin Punter. (2018). Diagnosis and management of cerebral venous thrombosis. Clinical Medicine. 18(1). 75–79. 49 indexed citations
10.
Behrouzi, Roya, Xiawei Liu, Andrew Robinson, et al.. (2016). Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy. Acta Neuropathologica Communications. 4(1). 33–33. 32 indexed citations
11.
Bryant, Jennifer, et al.. (2016). Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo. PLoS ONE. 11(2). e0148404–e0148404. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dagmara Klasa-Mazurkiewicz Breakdown of academic impact, for papers by Claire Edgerly Breakdown of academic impact, for papers by Jérôme Meunier Breakdown of academic impact, for papers by A.M. Guedj Breakdown of academic impact, for papers by N Sato Breakdown of academic impact, for papers by Javier de la Torre Breakdown of academic impact, for papers by Anne‐Sophie Chong Breakdown of academic impact, for papers by Anand Murugasu Breakdown of academic impact, for papers by C J Lips Breakdown of academic impact, for papers by Qiaoying Lv
Rankless by CCL
2026